DRUG DEPOT WITH ANCHOR
First Claim
1. A drug depot implantable at or near a target tissue site beneath the skin of a patient, the drug depot comprising a therapeutically effective amount of a drug;
- at least one line having a distal end and a proximal end, the proximal end of the line attached to the drug depot;
an anchor attached to the distal end of the line and configured to limit movement of the drug depot at or near the target tissue site, wherein the drug depot is capable of releasing the therapeutically effective amount of the drug over a period of at least one day.
1 Assignment
0 Petitions
Accused Products
Abstract
A drug depot implantable at or near a target tissue site beneath the skin of a patient is provided, the drug depot comprising a therapeutically effective amount of a drug; at least one line having a distal end and a proximal end, the proximal end of the line attached to the drug depot; an anchor attached to the distal end of the line and configured to limit movement of the drug depot at or near the target tissue site, wherein the drug depot is capable of releasing the therapeutically effective amount of the drug over a period of at least one day. In some embodiments, the drug depot provided can include an effective amount of at least analgesic and/or at least one anti-inflammatory agent at or near a target site, and can reduce, prevent or treat inflammation and/or pain.
30 Citations
20 Claims
-
1. A drug depot implantable at or near a target tissue site beneath the skin of a patient, the drug depot comprising a therapeutically effective amount of a drug;
- at least one line having a distal end and a proximal end, the proximal end of the line attached to the drug depot;
an anchor attached to the distal end of the line and configured to limit movement of the drug depot at or near the target tissue site, wherein the drug depot is capable of releasing the therapeutically effective amount of the drug over a period of at least one day. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11)
- at least one line having a distal end and a proximal end, the proximal end of the line attached to the drug depot;
-
12. A drug depot implantable at or near a target tissue site beneath the skin of a patient, the drug depot comprising a therapeutically effective amount of a drug;
- at least one suture having a distal end and a proximal end, the proximal end of the suture attached to the drug depot;
an anchor attached to the distal end of the suture and configured to limit movement of the drug depot at or near the target tissue site, wherein the drug depot is capable of releasing the therapeutically effective amount of the drug over a period of at least one day. - View Dependent Claims (13, 14, 15, 16, 17, 18)
- at least one suture having a distal end and a proximal end, the proximal end of the suture attached to the drug depot;
-
19. A method of treating or preventing pain or inflammation in a patient in need of such treatment, the method comprising implanting one or more biodegradable drug depots comprising a therapeutically effective amount of an analgesic and/or anti-inflammatory agent at or near a target tissue site beneath the skin, wherein the one or more drug depots comprise at least one biodegradable suture having a distal end and a proximal end, the proximal end of the at least one suture attached to the one or more drug depots;
- a biodegradable anchoring pellet attached to the distal end of the at least one suture and configured to limit movement of the one or more drug depots at or near the target tissue site, wherein the drug depot is capable of releasing the therapeutically effective amount of the drug over a period of at least three days.
- View Dependent Claims (20)
Specification